[e-drug] Consultation on pharmacogenetics and ethics

["Natalie Bartle" <nbartle@nuffieldfoundation.org>]

E-drug: Consultation on pharmacogenetics and ethics
---------------------------------------------

The Nuffield Council on Bioethics today issued a consultation paper on
ethical issues raised by the development of personalised medicines, or
pharmacogenetics.

The Nuffield Council on Bioethics was established in 1991 to identify,
examine and report on the ethical questions raised by recent advances in
biological and medical research.  The Council seeks to play a role in
contributing to policy-making and stimulating debate in bioethics.

In September 2002, the Council established a Working Party to consider
ethical, social, legal and regulatory issues raised by developments in
pharmacogenetics.  The Council intends to publish a report in the autumn
of 2003.

In order to inform the deliberations of the Working Party, we have
published a consultation document that poses a number of questions about
the implications of pharmacogenetics for the pharmaceutical industry,
providers of healthcare, and individual patients. The consultation paper
may be downloaded from our website:
www.nuffieldbioethics.org/pharmacogenetics.

Alternatively, contact the Council (bioethics@nuffieldfoundation.org) 
if you would like to obtain a printed copy.

We would welcome your comments on the issues raised. The deadline for
responses is 19 February 2003.

Please feel free to forward this message to other people who may be
interested in submitting a response.
Natalie Bartle
Nuffield Council on Bioethics
"Natalie Bartle" <nbartle@nuffieldfoundation.org>
[Please supply physical address with posting.  BS]
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug